Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
On-demand versus continuous omeprazole use in gastro-oesophageal reflux disease
2014-001314-25Phase 4Active
- Sponsor
- Karolinska Institutet
- Start
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of omeprazole in gastroesophageal reflux disease (GERD) (2 arms), sponsored by Karolinska Institutet. Primary endpoint: Presence and frequency of reflux symptoms. Started Jul 2014; status: active.
02
Drugs
omeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on 2014-001314-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001314-25.